In his role as Principal, Patrick leads a team of directors, senior associates and associates in executing executive search projects, de novo company builds, and investments across the firm’s expansive portfolio. Over the years he has partnered with a number of leading venture capital and private equity firms on CEO (15+), C-level, board, and other high-impact placements for their portfolio companies. Most recently, Patrick’s work includes companies (investors) like Signify Health (New Mountain Capital), OneOncology & Landmark Health (General Atlantic), CityMD / Helix / Specialists on Call (Warburg Pincus), Cotiviti (Veritas), Aetion (Flare, NEA), as well as Evolent Health (NYSE: EVH) and Prime Therapeutics.
In addition to being a talent partner across de novo, venture and growth equity, and publicly traded companies in Oxeon’s portfolio, Patrick has been supporting Town Hall Ventures investment efforts directly focused on underserved and complex populations. Patrick’s experience in the space began in a previous role helping manage the healthcare services portfolio at Oxford Finance, a healthcare and life sciences senior and venture debt provider. Much of Patrick’s healthcare experience has been focused around the complex and/or dual eligible and Medicare populations, which he’s been able to leverage with Oak Street Health, Commonwealth Care Alliance, Landmark Health, Longevity Health and a number of other Oxeon-invested clients who focus on Medicare and dual-eligible populations.
Inside the office, Patrick serves as the team’s Chief Laughter Officer and resident thespian. Meanwhile, outside of the office he can be found enjoying a cold (sometimes homemade) beer, skiing towards a lodge, trying to catch fish on a fly, cooking a feast or watching his beloved NY Jets let him down. Patrick holds a BS in Finance from the University of Delaware and holds Oxeon’s Founder & CEO, Trevor Price, responsible for the majority of his hair loss.